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polymorphisms and endometriosis risk:
a meta-analysis
Renyong Guo1†, Nengneng Zheng2†, Shiping Ding3, Ying Zheng2 and Limin Feng1*Abstract
Background: Many epidemiological studies have suggested an association between estrogen receptor-beta (ER-β)
polymorphisms with endometriosis risk. However, the results of these studies have been inconsistent. In the present
study, we performed a meta-analysis to clarify the associations between the ER-β rs4986938 and rs1256049
polymorphisms and endometriosis risk.
Methods: Eligible publications were retrieved from the PubMed, ISI Web of Science, and several Chinese language
databases. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using a random or fixed
effect model.
Results: A total of eight studies (1100 cases/1485 controls) for the rs4986938 polymorphism and four studies (353 cases/
450 controls) for the rs1256049 polymorphism were included in this meta-analysis. Regarding the rs4986938 polymorphism,
no obvious associations were found for all genetic models when all studies were pooled into the meta-analysis. In the
subgroup analyses by ethnicity, study sample size, endometriosis-associated infertility, and stage of endometriosis, a
significantly increased risk was observed among mixed populations (dominant model, OR = 2.03, 95% CI = 1.56–2.64)
and among cases with endometriosis-associated infertility (dominant model, OR = 1.83, 95% CI = 1.26–2.67). Regarding
the rs1256049 polymorphism, no obvious associations were found for all genetic models in the overall population.
Subgroup analyses by ethnicity and study sample size revealed that only one study of a mixed population with small
sample size showed an increased risk of endometriosis. No publication bias was found in the present study.
Conclusions: The results of this meta-analysis suggest that the ER-β rs4986938 and rs1256049 polymorphisms may not
be associated with endometriosis risk, while the observed increased risk of endometriosis-associated infertility may be
due to bias by the inclusion of small-scale studies.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
13000_2014_184
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Endometriosis is a steroid-dependent condition defined
by the presence of endometrial tissue outside of the
uterine cavity resulting in diverse clinical manifesta-
tions, such as infertility, pelvic pain, and dysmenorrhea
[1]. Endometriosis affects 3%–10% of reproductive-aged* Correspondence: limin_feng123@126.com
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unless otherwise stated.women and 20%–50% of women with infertility [2]. Sus-
ceptibility to endometriosis is dependent on a complex
interaction of genetic, immunological, and hormonal fac-
tors [3-5]; however, the exact etiology and pathogenesis of
the disease remain unclear.
Estrogen has been shown to play a critical role in the
growth of endometriotic tissues [6]. By binding to the
estrogen receptor (ER), estrogen triggers a broad array
of tissue and organ-specific physiological responses. There
are two isoforms of ERs, ER-α and ER-β, which exhibit
distinct distribution patterns among differentiated cells. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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translocated to the nucleus to activate gene transcription.
Previous studies have demonstrated that allelic variants of
genes encoding for ER may be responsible for their action
as modulators of the estrogenic response, and the poly-
morphisms of these genes have been postulated as candi-
date risk markers for a number of estrogen-dependent
disorders, including endometriosis [8,9]. The ER-β gene is
located on the long arm of chromosome 14 at locus 2
among subloci 23 and 24 (14q22–24). Two single nucleo-
tide polymorphisms (SNPs) in the ER-β gene, rs4986938
and rs1256049, have been most frequently studied. The
former SNP located in exon 8 gives rise to a G-A ex-
change at nucleotide 1730 and introduces a recognition
site for AluI, whereas the latter results in a G-A exchange
at nucleotide 1082 in exon 5 and creates a recognition site
for RsaI. In recent years, many meta-analyses have
reported associations of these two SNPs in the ER-β gene
with several diseases, including prostate cancer [10], male
infertility [11], Parkinson’s disease [12], osteoarthritis [13],
and breast cancer [14].
To date, a great number of case–control studies have
been conducted to investigate the associations between
the ER-β rs4986938 and rs1256049 polymorphisms and
endometriosis risk in humans. However, the results of
published studies are inconclusive and even controversial
[15-23], and the associations between ER-β gene polymor-
phisms and the risk of endometriosis-associated infertility
remain unclear, which could be due to differences in the
studied populations and insufficient statistical power. Thus,
we conducted this meta-analysis to explore the exact asso-
ciations between the rs4986938 and rs1256049 polymor-
phisms of the ER-β gene and risk of endometriosis.
Methods
Publication search
A systematic literature search of the PubMed, ISI Web
of Science, and several Chinese language databases
(Biomedical Literature Database, Chinese National Know-
ledge Infrastructure, and Chinese Wanfang Data) was car-
ried out to identify studies involving the associations
between the ER-β rs4986938 and rs1256049 polymor-
phisms and endometriosis risk. No language restrictions
were applied. To search and include as many related stud-
ies as possible, we used different combinations of the fol-
lowing key words: (estrogen receptor beta or estrogen
receptor β or ER-β) and (polymorphism or variant or mu-
tation) and endometriosis. All references of the retrieved
studies were also reviewed to identify other relevant
publications. Review articles were also searched to find
additional eligible studies. If more than one article was
published using the same study data, only the study with
largest sample size was included. The literature search
was updated on June 20, 2014.Inclusion and exclusion criteria
Studies fulfilling the following selection criteria were in-
cluded in this meta-analysis: (1) case–control design; (2)
evaluation of the correlation of the two SNPs (rs4986938
and rs1256049) of the ER-β gene with endometriosis
risk; (3) provision of sufficient data to calculate the odds
ratio (OR) and its corresponding 95% confidence interval
(CI). Studies were excluded if one of the following criteria
existed: (1) no relevance to the rs4986938 and rs1256049
polymorphisms, ER-β, and endometriosis; (2) non-clinical;
and (3) review articles or commentaries. When several
studies with overlapping data were eligible, those with
the smaller sample size or less reliability were excluded.
Furthermore, studies without detailed information were
excluded after efforts to extract data from the original
paper or contact the corresponding authors failed.
Data extraction
Two authors (Renyong Guo and Nengneng Zheng) in-
dependently assessed the quality of each study. Any
disagreement was resolved by consensus. The following
information was extracted: name of first author, year of
publication, country of origin, ethnicity of the study popu-
lation, number of cases and controls, mean age of subjects
and controls, number of infertility cases, genotype distri-
butions in cases and controls, and probability (p) value for
the test of Hardy–Weinberg equilibrium (HWE) in con-
trols. Discrepancies occurring during the process of study
selection and data extraction were resolved by discussion
with a third reviewer (Limin Feng) to arrive at a consensus
on each item.
Statistical analysis
The strength of an association between the two ER-β gene
polymorphisms and endometriosis risk was measured by
OR with its corresponding 95% CI. The pooled ORs were
calculated for the following four genetic models: (1) allelic
model: allele A vs. G, where A = variant allele and G =wild
allele, (2) homozygote comparison: AA vs. GG, (3) hetero-
zygote comparison: GA vs. GG, (4) dominant model: AA
+GA vs. GG, and (5) recessive model: AA vs. GA +GG.
The statistical significance of the pooled OR was assessed
with the Z test and a p value < 0.05 was considered statisti-
cally significant. A chi-square-based Q test was conducted
to measure the heterogeneity between eligible studies and
the existence of heterogeneity was considered significant
at p < 0.10 [24]. When between-study heterogeneity was
absent, a fixed effect model (Mantel–Haenszel method)
was used to pool the data from different studies [25];
otherwise, a random-effects model using the DerSimo-
nian–Laird method was applied [26]. Subgroup analyses
were also conducted based on ethnicity, study sample size,
endometriosis-associated infertility, and stage of endomet-
riosis. Sensitivity analyses were performed to identify the
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test the reliability of results by deleting a single study each
time [27]. Begg’s test and Egger’s test were performed to
determine the presence of publication bias with p < 0.05
considered statistically significant [28,29]. Data analysis
was performed using STATA statistical software (version
12.0; Stata Corporation, College Station, TX, USA).
Results
Characteristics of eligible studies
The literature search identified a total of 90 potentially
relevant papers. After removing 29 duplications and
reading the titles and abstracts, a further 45 articles
were excluded. A total of 16 remaining articles were
then retrieved for further assessment of eligibility.
Among these studies, seven were excluded because
they were (1) reviews or meta-analysis [30-33], (2) not
regarding gene polymorphisms [34], (3) an infertile
control study [35], or (4) lacked useful data [36]. Fi-
nally, a total of nine eligible articles were included in
this meta-analysis. The detailed screening process is
shown in Figure 1, which was modified according to
the Preferred Reporting Items for Systematic Reviews
and Meta-Analysis (PRISMA) Statement [37]. Among
these nine eligible studies, eight and four studies wereFigure 1 Flow chart of publication selection. A total of nine studies were in
study selection.pooled for analysis of the rs4986938 and rs1256049
polymorphisms, respectively. Regarding ethnicity, five
studies assessed Asians [15-17,20,22] and four studies
evaluated mixed ethnicities [18,19,21,23]. All of the in-
cluded studies employed a case–control design and the
genotype distributions among the controls of all stud-
ies were consistent with the HWE. The characteristics
of the included studies are listed in Table 1.
Quantitative synthesis
ER-β rs4986938 polymorphism
A total of seven studies with 1100 cases and 1485 con-
trols were included to examine the association between
the ER-β rs4986938 polymorphism and endometriosis
risk. The overall results suggested no statistically sig-
nificant association of this polymorphism with endo-
metriosis susceptibility (dominant model, OR = 1.21,
95% CI = 0.83–1.77; recessive model, OR = 0.86, 95%
CI = 0.41–1.77; AA vs. GG, OR= 0.95, 95% CI = 0.46–1.97;
GA vs. GG, OR = 1.24, 95% CI = 0.80–1.91; A vs. G,
OR = 1.16, 95% CI = 0.82–1.64; Table 2). In regard to
subgroup analysis by study sample size (≤300 and > 300
subjects), the non-associations in the above-mentioned
genetic models remained. However, further subgroup
analyses based on ethnicities demonstrated that thecluded in this meta-analysis and systematic review after a comprehensive
Table 1 Characteristics of the studies included in the meta-analysis of ER-β gene polymorphisms and endometriosis




Cases (Genotype) Controls Genotype) PHWE
b
Cases Controls Cases Controls G/G G/A A/A G/G G/A A/A
rs4986938
Wang [16] 2004 Japan Asia NA NA 127 180 NA HB 104 22 1 130 49 1 0.26
Huang [21] 2005 China Asia 35.0 ± 10.0 34.0 ± 10.0 110 115 NA PB 78 27 5 82 29 4 0.48
Lee [18] 2007 Korea Asia 33.8 ± 6.7 41.6 ± 10.7 239 287 NA HB 179 60 0 208 75 4 0.34
Bianco [19] 2009 Brazil Mixed 34.1 ± 4.2 39.8 ± 4.5 108 210 108 HB 55 51 2 156 51 3 0.61
Zulli [20] 2010 Brazil Mixed 33.7 ± 4.0 39.8 ± 4.5 136 209 136 HB 82 52 2 162 44 3 0.99
Gu [17] 2012 China Asia 45.0 ± 6.0 40.0 ± 19.0 58 107 NA HB 47 11 0 80 27 0 0.14
Christofolini [22] 2011 Brazil Mixed 35.2 ± 3.9 34.4 ± 4.7 201 206 201 HB 123 76 2 145 58 3 0.30
Wu [23] 2013 China Asia 30.9 ± 6.3 29.1 ± 4.3 121 171 121 NA 97 24a NA 140 31a NA >0.05
rs1256049
Wang [16] 2004 Japan Asia NA NA 131 182 NA HB 71 56 4 98 73 11 0.59
Huang [21] 2005 China Asia 35.0 ± 10.0 34.0 ± 10.0 110 115 NA PB 17 55 38 30 61 24 0.49
Silva [24] 2011 Brazil Mixed 32.5c 37.4c 54 46 27 NA 22 32 0 43 3 0 0.82
Gu [17] 2012 China Asia 45.0 ± 6.0 40.0 ± 19.0 58 107 NA HB 27 19 12 50 45 12 0.70
HB, hospital-based; PB, population-based; NA, not available; No., number.
















Table 2 Summary ORs and 95% CIs of the association between ER-β rs4986938 polymorphism and endometriosis
Comparison No. of
studies
A vs. Gb AA vs. GGa,b GA vs. GGb AA + GA vs. GG AA vs. GA + GGa,b
OR (95% CI) PH OR (95% CI) PH OR (95% CI) PH OR (95% CI) PH OR (95% CI) PH
Overall 8 1.16 (0.82-1.64)R <0.001 0.95 (0.46-1.97)F 0.735 1.24 (0.80-1.91)R <0.001 1.21 (0.83-1.77)R <0.001 0.86 (0.41-1.77)F 0.790
ethnicity
Asia 5 0.82 (0.65-1.04)F 0.552 0.75 (0.27-2.07)F 0.335 0.81 (0.62-1.05)F 0.456 0.85 (0.67-1.08)F 0.496 0.91 (0.26-3.13)F 0.331
Mixed 3 1.72 (1.37-2.17)c ,F 0.204 1.23 (0.43-3.49)F 0.795 2.08 (1.59-2.71)c ,F 0.159 2.03 (1.56-2.64)c ,F 0.148 0.97 (0.34-2.74)F 0.880
Sample size
>300 5 1.26 (0.82-1.93)R <0.001 0.83 (0.34-1.99)F 0.611 1.41 (0.82-2.40)R <0.001 1.38 (0.81-2.34)R <0.001 0.71 (0.30-1.73)F 0.717
≦300 3 0.94 (0.62-1.41)F 0.412 1.31 (0.34-5.07) - 0.86 (0.53-1.39)F 0.498 0.97 (0.67-1.39)F 0.624 1.32 (0.35-5.06) -
OR, odds ratio; CI, confidence interval; No., number; PH, p value of Q-test for heterogeneity test; R, random-effect model; F, fixed-effect model.
aThe study by Gu et al. was not included since they presented 0 frequency of AA genotype in cases and controls.
bThe study by Wu et al. was not included since they just presented the data on GG and GA + AA genotypes in cases and controls.
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http://www.diagnosticpathology.org/content/9/1/184ER-β rs4986938 polymorphism was significantly asso-
ciated with an increased risk of endometriosis in mixed
populations (dominant model, OR = 2.03, 95% CI =
1.56–2.64; GA vs. GG, OR = 2.08, 95% CI = 1.59–2.71;
A vs. G, OR = 1.72, 95% CI = 1.37–2.17; Table 2, Figure 2).
Additionally, four studies (566 cases and 796 controls)
[18,19,21,22] provided data between the rs4986938 poly-
morphism and risk of endometriosis-associated infertility.
The subsequent subgroup analysis showed that the ER-β
rs4986938 polymorphism was also significantly associated
with an increased risk of endometriosis-associated in-
fertility (dominant model, OR = 1.83, 95% CI = 1.26–
2.67; recessive model, OR = 0.96, 95% CI = 0.34–2.72;
AA vs. GG, OR = 1.23, 95% CI = 0.43–3.49; GA vs. GG,
OR = 2.08, 95% CI = 1.59–2.71; A vs. G, OR = 1.72, 95%
CI = 1.37–2.17; Figure 3). Data on genotype distributions of
the rs4986938 polymorphism in patients with stage I–II
and III–IV endometriosis were also available in three stud-
ies [17,18,21]. The results showed no significant association
of the rs4986938 polymorphism with stage of endometri-
osis (stage III–IV vs. stage I–II) (dominant model, OR =
1.01, 95% CI = 0.69–1.49; recessive model, OR = 0.34, 95%
CI = 0.05–2.29; AA vs. GG, OR= 0.33, 95% CI = 0.05–2.29;
GA vs. GG, OR= 1.05, 95% CI = 0.71–1.54; A vs. G, OR =
0.98, 95% CI = 0.70–1.36; Figure 4).
ER-β rs1256049 polymorphism
A total of 353 cases and 450 controls were identified to as-
sess the association between the rs1256049 polymorphismFigure 2 Meta-analysis for the association of the ER-β rs4986938 poly
(AA + GA vs. GG; stratified by ethnicity).and endometriosis risk. The overall results suggested
no statistically significant association of this poly-
morphism with endometriosis susceptibility (domin-
ant model, OR = 2.11, 95% CI = 0.85–5.26; recessive
model, OR = 1.43, 95% CI = 0.66–3.08; AA vs. GG,
OR = 1.50, 95% CI = 0.59–3.79; GA vs. GG, OR =
1.95, 95% CI = 0.75–5.09; A vs. G, OR = 1.71, 95% CI
= 0.92–3.16; Table 3). Further subgroup analysis sug-
gested that the effect size was only significant among
mixed populations (dominant model, OR = 20.85,
95% CI = 5.74–75.75; GA vs. GG, OR = 20.85, 95%
CI = 5.74–75.75; A vs. G, OR = 12.49, 95% CI = 3.68–
42.41), but not among Asian populations under all
genetic models (Figure 5). Subgroup analysis by study
sample size (≤200 and > 200 subjects) revealed no obvious
associations.
Heterogeneity test and sensitivity analysis
During the meta-analysis, significance of between-study
heterogeneity was observed (Tables 2 and 3). To explore
the source of heterogeneity, subgroup analyses by eth-
nicity and sample size were conducted. Furthermore,
sensitivity analyses were performed to explore the in-
fluence of each individual study on the overall results
by deleting a single study each time from the pooled
analysis. This procedure confirmed that our results of
the ER-β rs4986938 and rs1256049 polymorphisms and
endometriosis susceptibility were both reliable and robust
(Figure 6).morphism and endometriosis risk based on the dominant model
Figure 3 A forest plot of the relationship of the ER-β rs4986938 polymorphism with the risk of endometriosis-associated infertility
based on the dominant model (AA + GA vs. GG).
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To assess possible publication bias in the currently avail-
able literature, Begg’s test and Egger’s test were performed,
which showed no publication bias for studies published
on the rs4986938 and rs1256049 polymorphisms (all
p > 0.05, Table 4).
Discussion
ERs are nuclear receptors that contain an estrogen-binding
domain and a DNA-binding domain. Studies on tissue
distribution and expression patterns indicate that ER-α
has a broad expression pattern, whereas ER-β has a more
focused pattern with high levels in the ovary, prostate,
epididymis, lung, and hypothalamus [38]. Fazleabas et al.
examined expression levels of ER-α, ER-β, and progester-
one receptors in baboons and found that ER-β was the
dominant steroid receptor present in endometrioticFigure 4 A forest plot of the relationship of the ER-β rs4986938 polym
based on the dominant model (AA + GA vs. GG).explants, regardless of the cycle phase [39]. Two meta-
analyses demonstrated that the PvuII (T/C) and XbaI
(A/G) polymorphisms of the ER-α gene may not be as-
sociated with endometriosis risk [30,40]. Over the last
10 years, a great number of studies have investigated
the association between ER-β gene polymorphisms and
endometriosis risk, with most focused on the ER-β
rs4986938 and rs1256049 polymorphisms. However,
some of the results were conflicting, even in the same
population, and thus a systematic review and meta-
analysis of associations between ER-β gene polymor-
phisms and endometriosis risk will be of great value.
To the best of our knowledge, this is the first meta-
analysis to assess the relationship between the two ER-
β gene polymorphisms and endometriosis risk across
different ethnic populations and sample sizes. Even
though the association of endometriosis risk and geneticorphism with stage of endometriosis (stage III–IV vs. stage I–II)
Table 3 Summary ORs and 95% CIs of the association between ER-β rs1256049 polymorphism and endometriosis
Comparison No. of
studies
A vs. G AA vs. GGa GA vs. GG AA + GA vs. GG AA vs. GA + GGa
OR (95% CI) PH OR (95% CI) PH OR (95% CI) PH OR (95% CI) PH OR (95% CI) PH
Overall 4 1.71 (0.92-3.16)R <0.001 1.50 (0.59-3.79)R 0.059 1.95 (0.75-5.09)R <0.001 2.11 (0.85-5.26)R <0.001 1.43 (0.66-3.08)R 0.089
Ethnicity
Asia 3 1.23 (0.86-1.75)R 0.094 1.50 (0.59-3.79)R 0.059 1.09 (0.78-1.53)F 0.371 1.17 (0.85-1.61)F 0.229 1.43 (0.66-3.08)R 0.089
Mixed 1 12.49 (3.68-42.41)b - - - 20.85 (5.74-75.75)b - 20.85 (5.74-75.75)b - - -
Sample size
>200 2 1.22 (0.69-2.16)R 0.03 1.26 (0.23-6.76)R 0.018 1.20 (0.82-1.76)F 0.341 1.22 (0.85-1.77)F 0.101 1.08 (0.28-4.27)R 0.035
≦200 2 3.68 (0.36-37.65)R <0.001 1.85 (0.73-4.68) - 3.86 (0.15-102.43)R <0.001 4.35 (0.21-89.43)R <0.001 2.07 (0.86-4.95) -
OR, odds ratio; CI, confidence interval; No., number; PH, P value of Q-test for heterogeneity test; R, random-effect model; F, fixed-effect model.
aThe study by Silva et al. was not included since they presented 0 frequency of AA genotype in cases and controls.
















Figure 5 Meta-analysis for the association of the ER-β rs1256049 polymorphism and endometriosis risk based on the dominant model
(AA + GA vs. GG; stratified by ethnicity).
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http://www.diagnosticpathology.org/content/9/1/184polymorphisms involving biosynthesis of sex steroids and
their receptors was assessed in a previous meta-analysis
[30], the results only presented an allelic model of the
ER-β rs4986938 and rs1256049 polymorphisms from
five relevant studies. Our results suggested that there
was no significant association between the rs4986938
and rs1256049 polymorphisms in the ER-β gene and
endometriosis risk in the overall population, which was
consistent with the results of a previous meta-analysis
[30]. For the rs4986938 polymorphism, there was no
statistically significant association among study sample
size, stage of endometriosis, and Asian population in
further subgroup analyses. However, obvious associa-
tions were found among mixed populations for rs4986938Figure 6 Sensitivity analysis of the summary OR coefficients on the ass
with the risk of endometriosis based on the dominant model (AA+ GApolymorphisms under the allelic, heterogeneous co-
dominant and dominant models. Different ethnic groups
have unique genetic backgrounds and may produce varia-
tions of genetic factors involved in the pathogenesis of
endometriosis [18]. The results of subgroup analyses indi-
cated that ethnicity might be the source of heterogeneity
across studies. However, a characteristic of three studies
were mixed populations that included infertile Brazilian
women with endometriosis. Therefore, the rs4986938
polymorphisms may be not associated with endometriosis
risk, while the observed increase in the risk of endometri-
osis in mixed populations may be due to the complication
of infertility. Regarding the rs1256049 polymorphism, no
obvious associations were also found in all genetic modelsociations among the ER-β rs4986938 and rs1256049 polymorphisms
vs. GG).
Table 4 Statistical analyses of publication bias for ER-β gene polymorphisms
Category A vs. G AA vs. GG GA vs. GG AA + GA vs. GG AA vs. GA + GG
rs4986938
Begg’s test 0.548 0.452 1.00 0.902 0.452
Egger’s test 0.452 0.211 0.507 0.493 0.205
rs1256049
Begg’s test 0.308 0.296 0.734 0.089 0.296
Egger’s test 0.159 0.093 0.193 0.071 0.401
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study sample size. In the subgroup analyses based on eth-
nicity, however, only one study of a mixed population
found an increased risk of endometriosis under allelic,
heterogeneous co-dominant and dominant models of the
rs1256049 polymorphism. Inherent genetic differences
and variances in sample size between Asian and mixed
population studies might be a potential explanation for
the observed heterogeneity.
It should be noted that not all studies addressed the
correlation of ER-β gene polymorphisms with the
pathogenesis or risk of endometriosis-associated infer-
tility. Regarding the rs4986938 polymorphism, only
four studies evaluated the effect of interactions, with
three studies [18,19,21] providing complete data on
genotype distribution in cases and controls and one
[22] just presenting data on GG and GA+AA genotypes in
cases and controls. Regarding the rs1256049 polymorph-
ism, since only one study [23] for endometriosis-associated
infertility was investigated and the sample size was small,
subgroup analysis of endometriosis-associated infertility
was not performed. Nonetheless, the results demonstrated
a significant association between the rs4986938 polymorph-
ism and risk of endometriosis-associated infertility. Human
fertility is a complex feature influenced by interactions
between genetic and environmental factors. Saunders
et al. reported that the ER-β gene plays an important
role in the regulation of fertility in both males and fe-
males [41]. Another study performed with female ER-β
knockout mice also demonstrated that ER-β proteins,
which can be detected in multiple cell types throughout
the female reproductive system, are essential for normal
ovulation efficiency [42-44]. However, the functional
significance of the rs4986938 polymorphism remains to
be clarified. No amino acid changes in the ER-β protein
occur under the conditions of ER-β gene rs4986938
mutations, whereas these polymorphisms are possibly in
linkage disequilibrium with variations of other regula-
tory sequences that may affect gene expression or func-
tion [45]. Furthermore, structural folds of mRNA might
change, accounting for the existence of SNPs, and could
result in different biological functions that interact with
other cellular components [46]. Endometriosis is noted inup to 20%–50% of infertile women, but the reason why
women with endometriosis have impaired fertility remains
uncertain [2]. The above reason might partly explain the
potential association of polymorphic sites in the ER-β gene
with endometriosis and endometriosis-associated infertil-
ity among different populations. However, it would be of
great interest to characterize the actual relationship be-
tween ER-β gene polymorphisms and endometriosis and/
or infertility in a large-scale study.
Several limitations to this study should be addressed.
First, the results of our meta-analysis should be interpreted
with caution because the sample size was relatively small
for the subgroup analysis according to endometriosis-
associated infertility and stage of endometriosis. Second,
our meta-analyses were based on unadjusted estimates
and therefore potential covariates, which might influence
the effect estimates, were not controlled. Third, there were
relatively few studies on the association of the rs1256049
polymorphism and endometriosis. Therefore, subgroup
analysis according to endometriosis-associated infertility
and stage of endometriosis was not performed. Hence,
further studies with larger sample sizes to provide more
detailed information are needed
Conclusions
In conclusion, the results of this study suggest that the
ER-β rs4986938 and rs1256049 polymorphisms may be
not associated with endometriosis risk. However, ER-β
rs4986938 is likely associated with endometriosis-
associated infertility, and it might also act as a modifier
of the relationship between risk of endometriosis-
associated infertility and some environmental factors.
To date, there is insufficient evidence implicating the ER-β
rs4986938 polymorphism in the etiology of endometriosis-
associated infertility for population testing. The observed
increase in risk of endometriosis-associated infertility may
be due to bias because of the inclusion of small-scale
studies. It is critical that larger and well-designed mul-
ticenter studies should be performed to re-evaluate po-
tential associations.
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